FDA Inspection
Joslin Diabetes Center Committee on Human StudiesJoslin Diabetes Center Committee on Human Studies – FDA Inspection, Oct 2, 2009
Record Details
This FDA Inspection record concerns Joslin Diabetes Center Committee on Human Studies, with an inspection on October 2, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 2, 2009
- Product Type
- Drugs
View Company Profile
ID · f280c53b-f8c7-4f74-9ca9-fdcfa7a65b4a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 621686
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 56.109(h)Children as subjects
- 21 CFR 56.108(a)(1)Initial and continuing reviews
- 21 CFR 56.108(a)(1)Reporting findings and actions to investigator/institution
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Joslin Diabetes Center Committee on Human Studies
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 27, 2018 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| June 27, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Joslin Diabetes Center Committee on Human Studies
- FDA Inspection 1082467 - 2018-11-27
- FDA Inspection 885331 - 2014-06-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.